Published in Neurology on December 29, 2010
The neuropathology of genetic Parkinson's disease. Mov Disord (2012) 1.73
Olfactory dysfunction in Parkinson disease. Nat Rev Neurol (2012) 1.73
Olfaction in Parkinson's disease and related disorders. Neurobiol Dis (2011) 1.51
Screening for VPS35 mutations in Parkinson's disease. Neurobiol Aging (2011) 1.12
Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. JAMA Neurol (2014) 0.95
Phenotype analysis in patients with early onset Parkinson's disease with and without parkin mutations. J Neurol (2011) 0.89
Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation. Mov Disord (2013) 0.77
The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study. Mov Disord (2014) 0.77
Olfaction in Parkin carriers in Chinese patients with Parkinson disease. Brain Behav (2017) 0.75
Olfaction in Parkin-associated Parkinson disease: another enigma. Neurology (2010) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature (1998) 21.49
Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav (1984) 6.50
Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med (2000) 4.98
Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol (2004) 3.79
Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol (2008) 2.73
Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology (1988) 2.72
Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol (2001) 2.50
Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol (2007) 2.40
Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol (2002) 2.37
Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients. Ann Neurol (2007) 1.88
Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain (2003) 1.68
Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers. Ann Neurol (2005) 1.60
Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol (2010) 1.56
Distribution, type, and origin of Parkin mutations: review and case studies. Mov Disord (2004) 1.54
Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India. J Neurol Neurosurg Psychiatry (2009) 1.48
How much phenotypic variation can be attributed to parkin genotype? Ann Neurol (2003) 1.44
Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol (2001) 1.42
Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Arch Neurol (2010) 1.38
Olfaction in neurodegenerative disorder. Mov Disord (2003) 1.36
Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease. Mov Disord (2009) 1.36
Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology (2002) 1.32
Impact of recent genetic findings in Parkinson's disease. Curr Opin Neurol (2007) 1.22
Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism. Brain (2004) 1.16
The olfactory and cognitive deficits of Parkinson's disease: evidence for independence. Ann Neurol (1989) 1.14
Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations. Neurology (2009) 1.10
Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease. Neurology (2004) 1.06
Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's Disease. Eur J Neurol (2006) 1.04
Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease. J Neurol Neurosurg Psychiatry (2009) 0.99
Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations. Mov Disord (2009) 0.99
Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics? Neurology (2008) 0.99
Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2. BMC Neurol (2008) 0.91
The nigrostriatal dopaminergic system in familial early onset parkinsonism with parkin mutations. Neurology (2001) 0.91
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations. Mov Disord (2009) 0.90
Clinical features and gene analysis in Korean patients with early-onset Parkinson disease. Arch Neurol (2006) 0.88
Steele-Richardson-Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein. Mov Disord (2002) 0.87
The sequence of the human genome. Science (2001) 101.55
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
Physical properties and gel electrophoresis behavior of R12-derived plasmid DNAs. Nucleic Acids Res (1977) 13.19
Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med (2001) 9.51
The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA (1998) 7.81
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet (1996) 7.10
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology (2006) 6.86
Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology (1999) 6.03
Core assessment program for intracerebral transplantations (CAPIT). Mov Disord (1992) 5.51
Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry (2007) 5.49
Parkinson disease in twins: an etiologic study. JAMA (1999) 5.45
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet (1997) 5.39
Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet (1992) 5.12
Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nat Genet (1995) 5.11
Aligning conservation priorities across taxa in Madagascar with high-resolution planning tools. Science (2008) 5.07
Dissociation and reassociation of RTF and r-determinants of the R-factor NR1 in Proteus mirabilis. Nat New Biol (1971) 4.80
The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet (1993) 4.70
Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet (1996) 4.09
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology (2010) 4.06
Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA (1997) 4.00
Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology (1995) 3.91
Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A (1999) 3.85
A mechanism for nuclear positioning in fission yeast based on microtubule pushing. J Cell Biol (2001) 3.70
Validity and reliability of a rating scale for the primary torsion dystonias. Neurology (1985) 3.56
Huntington disease: clinical care and evaluation. Neurology (1979) 3.54
Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry (2000) 3.54
DNA restriction fragment analysis to define an extended cluster of tuberculosis in homeless men and their associates. J Infect Dis (1993) 3.43
Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology (1995) 3.37
Increased auditory cortical representation in musicians. Nature (1998) 3.33
Delayed-onset dystonia in patients with "static" encephalopathy. J Neurol Neurosurg Psychiatry (1980) 3.19
Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA (1997) 3.17
umuDC and mucAB operons whose products are required for UV light- and chemical-induced mutagenesis: UmuD, MucA, and LexA proteins share homology. Proc Natl Acad Sci U S A (1985) 3.14
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology (2012) 3.12
The role of radiotracer imaging in Parkinson disease. Neurology (2005) 3.02
The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol (1995) 3.00
Recent developments in molecular epidemiology: A study of the effects of environmental polycyclic aromatic hydrocarbons on birth outcomes in Poland. Am J Epidemiol (1998) 2.96
The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology (1997) 2.96
Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Mov Disord (2005) 2.88
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol (1996) 2.86
Yawning as an aura for an L-dopa-induced "on" in Parkinson's disease. Neurology (1998) 2.80
Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA (2001) 2.79
Round of replication mutant of a drug resistance factor. J Bacteriol (1974) 2.77
Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab? Aliment Pharmacol Ther (2012) 2.74
Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet (1994) 2.60
Increased risk for recurrent major depression in DYT1 dystonia mutation carriers. Neurology (2004) 2.59
Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum Mol Genet (1998) 2.57
Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology (2012) 2.50
Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol (2001) 2.50
The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol (1993) 2.48
The molecular nature and replication of drug resistance factors of the Enterobacteriaceae. Ann N Y Acad Sci (1971) 2.47
Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk. Neurology (2003) 2.44
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology (2007) 2.41
Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology (2005) 2.41
On meta-analytic assessment of surrogate outcomes. Biostatistics (2000) 2.41
The DYT1 phenotype and guidelines for diagnostic testing. Neurology (2000) 2.39
A massive epidemic of multidrug-resistant typhoid fever in Tajikistan associated with consumption of municipal water. J Infect Dis (1999) 2.39
The impact of depressive symptoms in early Parkinson disease. Neurology (2007) 2.37
Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA (2001) 2.36
Isolation, by tetracycline selection, of small plasmids derived from R-factor R12 in Escherichia coli K-12. J Bacteriol (1976) 2.33
Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family. Nature (1998) 2.28
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology (2012) 2.26